FNORX Performance — Fidelity Nordic Fund
Data updated: 2026-09-23
FNORX returned +8.67% year to date and +21.89% over one year to Jul 2026. Annualised returns are +12.97% over 3 years and +4.77% over 5 years. The fund beat its Europe Equity category average: $100 invested three years ago grew to $144, against $124 for the category, and to $122 over one year, against $97. Volatility over the past three years was 15.08% a year. In the 12 months to Jul 2026 the fund lost a net $1.9M, and assets reached $352.99M.
FNORX Growth of $100
What $100 invested in Fidelity Nordic Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Europe Equity category average over the same months.
| Period | FNORX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $122 | $97 |
| 3 years (Aug 2023 – Jul 2026) | $144 | $124 |
| 5 years (Aug 2021 – Jul 2026) | $126 | $116 |
| Since data start (Aug 2019 – Jul 2026) | $230 | $156 |
FNORX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.67% |
| 1 year | +21.89% |
| 3 years (annualised) | +12.97% |
| 5 years (annualised) | +4.77% |
FNORX Annual Returns
Calendar-year total returns of Fidelity Nordic Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +8.67% |
| 2025 | +25.93% |
| 2024 | −4.57% |
| 2023 | +20.92% |
| 2022 | −19.30% |
| 2021 | +13.10% |
| 2020 | +43.01% |
| 2019 (Aug–Dec) | +11.75% |
FNORX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.9% | −0.5% | −5.3% | +8.0% | +3.1% | −4.4% | +0.4% | — | — | — | — | — |
| 2025 | +5.1% | +4.5% | −1.2% | +3.0% | +4.8% | +2.5% | −6.5% | +3.9% | +1.5% | +1.7% | −0.5% | +5.2% |
| 2024 | +0.1% | +3.8% | +3.0% | −2.1% | +7.2% | −1.2% | +0.1% | +3.3% | −2.8% | −6.7% | −2.5% | −6.1% |
| 2023 | +3.8% | +2.5% | +3.2% | +3.4% | −5.5% | +1.6% | +0.4% | −1.5% | −1.8% | −2.9% | +10.0% | +6.8% |
| 2022 | −9.4% | −8.1% | +2.4% | −6.2% | +0.5% | −9.7% | +9.7% | −7.8% | −10.3% | +8.7% | +12.9% | −0.1% |
| 2021 | −1.2% | +1.1% | +1.8% | +6.1% | +2.8% | −1.4% | +4.4% | +0.9% | −6.0% | +5.6% | −5.1% | +4.2% |
| 2020 | −2.0% | −4.6% | −12.9% | +9.0% | +9.1% | +2.5% | +12.4% | +7.7% | +0.5% | −2.0% | +12.6% | +7.3% |
| 2019 | — | — | — | — | — | — | — | −0.7% | +2.1% | +2.9% | +2.6% | +4.4% |
FNORX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 15.08%
- 3-year Sharpe ratio: 0.56 (vs 4.5% risk-free rate)
- Best month: +9.99% (Nov 2023)
- Worst month: −6.65% (Oct 2024)
FNORX Fund Flows
Monthly money in and out of Fidelity Nordic Fund, from SEC Form N-PORT.
- 12-month net flow: −$1.9M
- 12-month gross sales (incl. reinvestments): $59.1M
- Sales ÷ redemptions: 0.97×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.6M | $3.4M | $1.2M |
| Jun 2026 | $2.4M | $4.0M | −$1.6M |
| May 2026 | $2.4M | $3.5M | −$1.1M |
| Apr 2026 | $2.0M | $7.5M | −$5.4M |
| Mar 2026 | $1.8M | $5.4M | −$3.6M |
| Feb 2026 | $5.6M | $5.4M | $221K |
| Jan 2026 | $6.3M | $5.5M | $793K |
| Dec 2025 | $26.7M | $5.6M | $21.1M |
| Nov 2025 | $1.8M | $5.4M | −$3.5M |
| Oct 2025 | $2.2M | $5.4M | −$3.2M |
| Sep 2025 | $1.9M | $4.0M | −$2.1M |
| Aug 2025 | $1.4M | $6.1M | −$4.7M |
FNORX Assets Under Management
Net assets of Fidelity Nordic Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $352.99M |
| 2026-04-30 | $357.89M |
| 2026-01-31 | $361.08M |
| 2025-10-31 | $328.73M |
| 2025-07-31 | $316.34M |
| 2025-04-30 | $317.53M |
| 2025-01-31 | $302.53M |
| 2024-10-31 | $332.05M |
| 2024-07-31 | $356.13M |
| 2024-04-30 | $338.49M |
| 2024-01-31 | $330.24M |
| 2023-10-31 | $286.96M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.